University of Miami-Miller School of Medicine: Sylvester Researchers Find PARP Inhibitors Could Be New Treatment for Common Lymphoma
October 25, 2019
October 25, 2019
MIAMI, Florida, Oct. 25 [TNSmedicalresearch - Cancer Cell] -- The University of Miami's Miller School of Medicine issued the following news:
A study looking at PARP inhibition in diffuse large B cell lymphoma opens the door to a new way to treat this common type of cancer, according to study author Izidore S. Lossos, M.D., endowed director of the Lymphoma Program at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and head of the Hematologi . . .
A study looking at PARP inhibition in diffuse large B cell lymphoma opens the door to a new way to treat this common type of cancer, according to study author Izidore S. Lossos, M.D., endowed director of the Lymphoma Program at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and head of the Hematologi . . .